From the Departments of Ophthalmology and Vision Sciences (M.T.M., C.A.W.) and Neurology (B.M., O.C.S.), The Hospital for Sick Children; Kensington Eye Institute (T.W.), Toronto; and Institute of Medical Science (O.C.S., C.A.W.) and Ophthalmology and Vision Sciences (C.A.W.), University of Toronto, Canada.
Neurology. 2020 Feb 11;94(6):e575-e582. doi: 10.1212/WNL.0000000000008686. Epub 2019 Dec 2.
To determine the prevalence of retinal defect in children with infantile spasms (IS) unrelated to treatment with vigabatrin and clarify if specific primary etiologies for IS are associated with retinal defect more than others.
This was an observational cohort study including 312 patients (176 male, 136 female) with IS who were vigabatrin-naive. Participants ranged from 1.7 to 34.7 months of age (mean 8.8 months). Electroretinograms (ERGs) were performed according to the International Society for Clinical Electrophysiology of Vision. Retinal defect was identified as abnormal if the 30-Hz flicker ERG amplitude was lower than the age-corrected normal 95% prediction interval. The primary etiology for IS, as determined by the treating pediatric neurologist(s), was obtained from patient health records and classified into 1 of 9 etiologic subgroups: (1) genetic disorders alone, (2) genetic-structural disorders, (3) structural-congenital, (4) structural-acquired (perinatal), (5) structural-acquired (postnatal), (6) metabolic disorders, (7) immunologic disorders, (8) infectious, and (9) unknown causes.
Fifty-nine of the 312 vigabatrin-naive children (18.9%) showed retinal defect and the prevalence of retinal defect was highest (24.4%) in the structural-acquired (perinatal) subgroup, which included hypoxic-ischemic defect. Retinal function compared across subgroups showed no significant difference.
Care is required in diagnosing retinal toxicity, which would be enhanced by baseline flicker ERG in children with IS prior to starting vigabatrin.
确定与氨己烯酸无关的婴儿痉挛症(IS)患儿的视网膜缺陷发生率,并阐明 IS 的特定原发性病因与视网膜缺陷的相关性是否大于其他病因。
这是一项观察性队列研究,纳入了 312 例(男 176 例,女 136 例)未接受氨己烯酸治疗的 IS 患儿。参与者年龄为 1.7 至 34.7 个月(平均 8.8 个月)。根据国际临床视觉电生理学协会的标准进行视网膜电图(ERG)检查。如果 30-Hz 闪烁 ERG 振幅低于年龄校正的正常 95%预测区间,则将视网膜缺陷定义为异常。根据治疗小儿神经科医生的判断,确定 IS 的原发性病因,并从患者病历中获取病因并分为 9 个病因亚组之一:(1)单纯遗传疾病,(2)遗传-结构疾病,(3)结构-先天性,(4)结构-获得性(围产期),(5)结构-获得性(产后),(6)代谢疾病,(7)免疫疾病,(8)感染,(9)未知原因。
在 312 例未接受氨己烯酸治疗的儿童中,有 59 例(18.9%)出现视网膜缺陷,在结构获得性(围产期)亚组中视网膜缺陷的发生率最高(24.4%),其中包括缺氧缺血性缺陷。在亚组间比较视网膜功能时,未发现显著差异。
在开始使用氨己烯酸之前,对 IS 患儿进行基线闪烁 ERG 检查有助于提高诊断视网膜毒性的准确性。